$2.13
0.094.41%
At close: -
$2.13
0.000100.00%
After Hours: Mar 21, 7:53 PM EDT
Comments
Loading...
Akebia Therapeutics Insider Trading Activity | NASDAQ:AKBA | Benzinga
Track the latest Akebia Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Akebia Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Akebia Therapeutics Inc Insiders Doing?
At Akebia Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 53.55K shares worth $98.00K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 4, 2025, Steven K. Burke, the company's SVP, CHIEF MEDICAL OFFICER sold 7.14K shares for $1.83 each.
- On March 4, 2025, John P Butler, the company's CEO AND PRESIDENT sold 46.41K shares for $1.83 each.
Ownership Statistics for Akebia Therapeutics Inc
Shares Outstanding
261.231M
Insider Shares Owned
9.012M
Insider Percentage Owned
4.13%
Institutional Shares Held
44.531M
Institutional Percentage Held
20.4%
| Mar 04, 2025 | John P Butler | CEO AND PRESIDENT | -46.41K | $1.83 | -$84.93K | SELL | -1.74% | 2.62M | Mar 03 | View |
| Mar 04, 2025 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -7.14K | $1.83 | -$13.07K | SELL | -0.88% | 809.09K | Mar 03 | View |
| Feb 04, 2025 | John P Butler | CEO AND PRESIDENT | 556.75K | $2.10 | -$302.93K | GRANT | 26.42% | 2.66M | Jan 31 - Feb 03 | View |
| Feb 04, 2025 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 144.39K | $2.10 | -$106.06K | GRANT | 21.49% | 816.23K | Jan 31 - Feb 03 | View |
| Feb 04, 2025 | Richard C Malabre | SVP, CHIEF ACCOUNTING OFFICER | 54.80K | $2.10 | -$63.42K | GRANT | 24.31% | 280.25K | Jan 31 - Feb 03 | View |
| Feb 04, 2025 | Nicholas Grund | CHIEF COMMERCIAL OFFICER | 139.28K | $2.10 | -$116.80K | GRANT | 45.92% | 442.58K | Jan 31 - Feb 03 | View |
| May 14, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -12.02K | $1.26 | -$15.14K | SELL | -1.81% | 651.24K | May 13 | View |
| May 14, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -34.84K | $1.26 | -$43.90K | SELL | -4.93% | 672.09K | May 13 | View |
| May 09, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -27.00K | $1.15 | -$31.05K | SELL | -3.88% | 668.84K | Aug 25 | View |
| Mar 01, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -8.66K | $1.58 | -$13.68K | SELL | -1.21% | 706.93K | Feb 29 | View |
| Mar 01, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -5.97K | $1.58 | -$9.44K | SELL | -0.89% | 663.26K | Feb 29 | View |
| Mar 01, 2024 | John P Butler | CEO AND PRESIDENT | -46.57K | $1.58 | -$73.58K | SELL | -2.16% | 2.10M | Feb 29 | View |
| Mar 01, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -7.17K | $1.58 | -$11.33K | SELL | -1.02% | 695.84K | Feb 29 | View |
| Feb 29, 2024 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -7.41K | $1.52 | -$11.26K | SELL | -1.10% | 669.23K | Feb 27 | View |
| Feb 29, 2024 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -10.74K | $1.52 | -$16.33K | SELL | -1.48% | 715.59K | Feb 27 | View |
| Feb 29, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -8.37K | $1.52 | -$12.72K | SELL | -1.18% | 703.01K | Feb 27 | View |
| Feb 29, 2024 | John P Butler | CEO AND PRESIDENT | -37.73K | $1.52 | -$57.35K | SELL | -1.72% | 2.15M | Feb 27 | View |
| Feb 02, 2024 | John P Butler | CEO AND PRESIDENT | 557.01K | $1.68 | -$78.10K | GRANT | 34.13% | 2.19M | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 177.89K | $1.68 | -$40.84K | GRANT | 33.34% | 711.38K | Jan 31 - Feb 01 | View |
| May 25, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 136.81K | $1.22 | -$77.27K | GRANT | 35.30% | 524.34K | May 24 - May 25 | View |
| May 25, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 104.52K | $1.22 | -$116.76K | GRANT | 22.26% | 574.04K | May 24 - May 25 | View |
| May 18, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -63.57K | $1.07 | -$67.89K | SELL | -10.70% | 530.49K | May 16 | View |
| May 18, 2023 | David A Spellman | SVP, CFO AND TREASURER | -63.57K | $1.07 | -$67.89K | SELL | -12.46% | 446.48K | May 16 | View |
| Mar 03, 2023 | John P Butler | CEO AND PRESIDENT | -91.87K | $0.88 | -$80.61K | SELL | -5.34% | 1.63M | Mar 01 | View |
| Mar 03, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -13.03K | $0.88 | -$11.44K | SELL | -4.34% | 287.53K | Mar 01 | View |
| Mar 03, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -14.12K | $0.88 | -$12.39K | SELL | -2.32% | 594.05K | Mar 01 | View |
| Mar 03, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -20.41K | $0.88 | -$17.91K | SELL | -7.04% | 269.51K | Mar 01 | View |
| Mar 03, 2023 | David A Spellman | SVP, CFO AND TREASURER | -7.21K | $0.88 | -$6.33K | SELL | -1.39% | 510.05K | Mar 01 | View |
| Mar 01, 2023 | John P Butler | CEO AND PRESIDENT | -38.63K | $0.81 | -$31.42K | SELL | -2.20% | 1.72M | Feb 27 | View |
| Mar 01, 2023 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -7.54K | $0.81 | -$6.13K | SELL | -1.22% | 608.18K | Feb 27 | View |
| Mar 01, 2023 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -10.09K | $0.81 | -$8.21K | SELL | -3.36% | 289.93K | Feb 27 | View |
| Mar 01, 2023 | David A Spellman | SVP, CFO AND TREASURER | -7.54K | $0.81 | -$6.13K | SELL | -1.44% | 517.26K | Feb 27 | View |
| Mar 01, 2023 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -6.68K | $0.81 | -$5.43K | SELL | -2.17% | 300.56K | Feb 27 | View |
| Sep 01, 2022 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.15K | $0.36 | -$415.79 | SELL | -0.27% | 418.02K | Aug 31 | View |
| Jun 07, 2022 | Steven C Gilman | — | -4.57K | $0.36 | -$1.65K | SELL | -9.52% | 43.43K | Jun 03 | View |
| Mar 02, 2022 | John P Butler | CEO AND PRESIDENT | 214.10K | $2.17 | -$171.14K | GRANT | 16.61% | 1.50M | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 44.94K | $2.16 | -$32.56K | GRANT | 26.02% | 217.66K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Violetta Cotreau | SVP, CHIEF ACCOUNTING OFFICER | 36.89K | $2.15 | -$8.50K | GRANT | 111.55% | 69.95K | Feb 28 | View |
| Mar 02, 2022 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 28.47K | $2.17 | -$46.64K | GRANT | 10.60% | 297.02K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Dell Faulkingham | SVP, CCO | 36.82K | $2.16 | -$28.52K | GRANT | 26.87% | 173.84K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 28.94K | $2.17 | -$45.62K | GRANT | 10.51% | 304.24K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | David A Spellman | SVP, CFO AND TREASURER | 51.80K | $2.16 | -$17.69K | GRANT | 67.44% | 128.60K | Feb 28 - Mar 01 | View |
| Jan 05, 2022 | Violetta Cotreau | SVP, CHIEF ACCOUNTING OFFICER | -5.83K | $2.29 | -$13.34K | SELL | -14.99% | 33.07K | Jan 03 | View |
| Sep 02, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.04K | $2.83 | -$2.95K | SELL | -0.60% | 171.22K | Aug 31 | View |
| Jun 09, 2021 | Steven C Gilman | — | -4.57K | $3.32 | -$15.16K | SELL | -8.69% | 48.00K | Jun 07 | View |
| Apr 01, 2021 | Dell Faulkingham | SVP, CCO | -952.00 | $3.40 | -$3.24K | SELL | -0.69% | 137.03K | Apr 01 | View |
| Apr 01, 2021 | David A Spellman | SVP, CFO AND TREASURER | -790.00 | $3.40 | -$2.69K | SELL | -1.02% | 76.80K | Apr 01 | View |
| Apr 01, 2021 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | -1.06K | $3.40 | -$3.60K | SELL | -0.39% | 272.30K | Apr 01 | View |
| Apr 01, 2021 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | -1.21K | $3.40 | -$4.12K | SELL | -0.45% | 265.55K | Apr 01 | View |
| Apr 01, 2021 | John P Butler | CEO AND PRESIDENT | -4.11K | $3.40 | -$13.97K | SELL | -0.35% | 1.18M | Apr 01 | View |
| Apr 01, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | -1.08K | $3.40 | -$3.68K | SELL | -0.63% | 170.76K | Apr 01 | View |
| Mar 02, 2021 | John P Butler | CEO AND PRESIDENT | 187.41K | $3.40 | -$169.77K | GRANT | 19.51% | 1.15M | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Dell Faulkingham | CCO | 55.25K | $3.40 | -$22.92K | GRANT | 75.10% | 128.82K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Nicole R Hadas | SVP, CHIEF LEGAL OFFICER | 47.72K | $3.40 | -$48.51K | GRANT | 22.15% | 263.17K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Michel Dahan | SVP, CHIEF OPERATING OFFICER | 47.45K | $3.40 | -$49.40K | GRANT | 22.85% | 255.11K | Feb 26 - Mar 01 | View |
| Mar 02, 2021 | Steven K. Burke | SVP, CHIEF MEDICAL OFFICER | 62.44K | $3.40 | -$25.67K | GRANT | 63.07% | 161.44K | Feb 26 - Mar 01 | View |
| Jun 09, 2020 | Cynthia Smith | — | 9.13K | $12.10 | -$55.26K | GRANT OR AWARD | 31.82% | 37.83K | Jun 05 - Jun 08 | View |
| Jun 09, 2020 | Steven C Gilman | — | 9.13K | $12.08 | -$55.17K | GRANT OR AWARD | 30.72% | 38.86K | Jun 05 - Jun 08 | View |
| Jun 09, 2020 | Maxine Gowen | — | 9.13K | $12.05 | -$55.03K | GRANT OR AWARD | 60.89% | 24.13K | Jun 05 - Jun 08 | View |
| Jun 02, 2020 | Dell Faulkingham | — | -6.43K | $11.58 | -$74.41K | SELL | -8.03% | 73.57K | Jun 01 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.